Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Tissue hybridization in situ diagnosis and detection system for BKV and application thereof

An in situ hybridization and tissue technology, applied in the field of genetic diagnosis, can solve the problems of poor DNA sensitivity, increase the intensity of immunosuppression, and easily lead to misjudgment, so as to improve sensitivity and specificity, broad market application prospects, and improve sensitivity Effect

Active Publication Date: 2019-12-24
SHANGHAI PUBLIC HEALTH CLINICAL CENT
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, this detection technique has the following deficiencies: 1) poor specificity, which easily leads to misjudgment
2) The sensitivity is poor, which can easily lead to missed judgments
Therefore, once BKV-related nephritis is missed as BKV false negative, it will be judged as acute rejection, and the intensity of immunosuppression needs to be increased, which will lead to the aggravation of BKV-related nephritis symptoms and cause serious consequences such as transplanted kidney failure
At present, there are sporadic reports on the diagnosis of BKV in situ hybridization in the literature, but because the target site is not limited to the gene coding region, or only considers the BKV conserved region but not the specific region, it can only target DNA (a small amount) ) problem of poor sensitivity; or probes targeting BKV, JCV and SV40 at the same time and cannot distinguish the problem of poor specificity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tissue hybridization in situ diagnosis and detection system for BKV and application thereof
  • Tissue hybridization in situ diagnosis and detection system for BKV and application thereof
  • Tissue hybridization in situ diagnosis and detection system for BKV and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] The present invention will be further described below in combination with specific embodiments. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the contents of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.

[0022] The specific embodiments provided by the present invention will be described in detail below in conjunction with the accompanying drawings.

[0023] (1) Analyze the virological characteristics of BKV and select detection targets.

[0024] BKV is a DNA double-stranded virus with a genome length of about 5300bp, including early coding genes (coding regulatory proteins large T and small T), late coding genes (coding ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of gene diagnosis, in particular to an in-situ nucleic acid diagnosis and detection system for BKV. The in-situ nucleic acid diagnosis and detection systemcomprises probes used for detecting the BKV, sequences of the probes are the sequences or complementary chains correspondingly shown in SEQ ID NO: 1-40. The invention further discloses application ofthe in-situ nucleic acid diagnosis and detection system to preparation of diagnosis or detection reagents / kits for the BKV. The tissue hybridization in situ diagnosis and detection system for the BKVis high in sensitivity and good in specificity, and can be used for accurately diagnosing the activation of the BKV to guide clinical symptomatic medication, and the sensitivity and specificity of the BKV tissue diagnosis are improved. According to the application of the BKV hybridization in situ technology, the sensitivity and specificity of the BKV tissue diagnosis can be greatly improved, theharm caused by BKV related diseases is reduced, and wide market application prospects are achieved.

Description

technical field [0001] The invention relates to the technical field of gene diagnosis, in particular to an in-situ nucleic acid diagnosis and detection system for BKV and its application. Background technique [0002] In situ hybridization (In-Situ Hybridization, ISH) is a technology that uses nucleic acid molecular probes to quantify and locate specific nucleic acid (DNA and RNA) targets in fixed tissues and cells, and can obtain time and space related to gene expression and genetic loci Information is one of the commonly used methods of tissue diagnosis in clinic. Immunohistochemistry (IHC) is the most commonly used method in tissue diagnosis. It utilizes the principle of antigen-antibody specific binding, carries out color reaction through antibody labeling, and performs qualitative, localization, and quantitative determination of the corresponding antigen (i.e., protein). a technology. BK polyomavirus (BKpolyomavirus, BKV) is a kind of opportunistic infection virus tha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/70C12Q1/6841C12N15/11C12R1/93
CPCC12Q1/701C12Q1/6841C12Q2563/107Y02A50/30
Inventor 朱同玉吴楠楠胡春兰张小楠石业静
Owner SHANGHAI PUBLIC HEALTH CLINICAL CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products